Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BEAT vs HSDT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BEAT
HeartBeam, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$36M
5Y Perf.-75.1%
HSDT
Solana Company

Medical - Devices

HealthcareNASDAQ • US
Market Cap$89M
5Y Perf.-100.0%

BEAT vs HSDT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BEAT logoBEAT
HSDT logoHSDT
IndustryMedical - Healthcare Information ServicesMedical - Devices
Market Cap$36M$89M
Revenue (TTM)$0.00$6M
Net Income (TTM)$-21M$-41M
Gross Margin91.7%
Operating Margin-351.0%
Total Debt$0.00$0.00
Cash & Equiv.$4M$7M

BEAT vs HSDTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BEAT
HSDT
StockNov 21May 26Return
HeartBeam, Inc. (BEAT)10024.9-75.1%
Solana Company (HSDT)1000.0-100.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: BEAT vs HSDT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BEAT and HSDT are tied at the top with 2 categories each — the right choice depends on your priorities. Solana Company is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. As sector peers, any of these can serve as alternatives in the same allocation.
BEAT
HeartBeam, Inc.
The Income Pick

BEAT has the current edge in this matchup, primarily because of its strength in income & stability and long-term compounding.

  • beta 1.27
  • -81.0% 10Y total return vs HSDT's -100.0%
  • Lower volatility, beta 1.27
Best for: income & stability and long-term compounding
HSDT
Solana Company
The Growth Play

HSDT is the clearest fit if your priority is growth exposure.

  • Rev growth 10.6%, EPS growth 57.3%, 3Y rev CAGR 97.0%
  • 10.6% revenue growth vs BEAT's -100.0%
  • -20.7% ROA vs BEAT's -353.1%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthHSDT logoHSDT10.6% revenue growth vs BEAT's -100.0%
Stability / SafetyBEAT logoBEATBeta 1.27 vs HSDT's 2.65
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)BEAT logoBEAT-50.8% vs HSDT's -99.0%
Efficiency (ROA)HSDT logoHSDT-20.7% ROA vs BEAT's -353.1%

BEAT vs HSDT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BEATHeartBeam, Inc.
FY 2019
MonitoringCommercial
49.7%$218M
MonitoringMedicare
35.0%$154M
ClinicalTrialSupportandRelatedServices
12.4%$54M
TechnologyDevicesConsumablesandRelatedServices
2.9%$13M
HSDTSolana Company
FY 2025
Product
76.6%$420,000
Product and Service, Other
23.4%$128,000

BEAT vs HSDT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBEATLAGGINGHSDT

Income & Cash Flow (Last 12 Months)

HSDT leads this category, winning 1 of 1 comparable metric.

HSDT and BEAT operate at a comparable scale, with $6M and $0 in trailing revenue.

MetricBEAT logoBEATHeartBeam, Inc.HSDT logoHSDTSolana Company
RevenueTrailing 12 months$0$6M
EBITDAEarnings before interest/tax-$21M-$21M
Net IncomeAfter-tax profit-$21M-$41M
Free Cash FlowCash after capex-$15M-$17M
Gross MarginGross profit ÷ Revenue+91.7%
Operating MarginEBIT ÷ Revenue-3.5%
Net MarginNet income ÷ Revenue-6.8%
FCF MarginFCF ÷ Revenue-2.7%
Rev. Growth (YoY)Latest quarter vs prior year+33.4%
EPS Growth (YoY)Latest quarter vs prior year+22.2%+3.9%
HSDT leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

Evenly matched — BEAT and HSDT each lead in 1 of 2 comparable metrics.
MetricBEAT logoBEATHeartBeam, Inc.HSDT logoHSDTSolana Company
Market CapShares × price$36M$89M
Enterprise ValueMkt cap + debt − cash$31M$82M
Trailing P/EPrice ÷ TTM EPS-1.44x-1.20x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue14.87x
Price / BookPrice ÷ Book value/share11.53x0.16x
Price / FCFMarket cap ÷ FCF
Evenly matched — BEAT and HSDT each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

HSDT leads this category, winning 5 of 5 comparable metrics.

HSDT delivers a -105.0% return on equity — every $100 of shareholder capital generates $-105 in annual profit, vs $-6 for BEAT. On the Piotroski fundamental quality scale (0–9), HSDT scores 4/9 vs BEAT's 1/9, reflecting mixed financial health.

MetricBEAT logoBEATHeartBeam, Inc.HSDT logoHSDTSolana Company
ROE (TTM)Return on equity-5.7%-105.0%
ROA (TTM)Return on assets-3.5%-20.7%
ROICReturn on invested capital-10.8%
ROCEReturn on capital employed-4.6%-14.0%
Piotroski ScoreFundamental quality 0–914
Debt / EquityFinancial leverage
Net DebtTotal debt minus cash-$4M-$7M
Cash & Equiv.Liquid assets$4M$7M
Total DebtShort + long-term debt$0$0
Interest CoverageEBIT ÷ Interest expense-63.39x
HSDT leads this category, winning 5 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

BEAT leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in BEAT five years ago would be worth $1,898 today (with dividends reinvested), compared to $0 for HSDT. Over the past 12 months, BEAT leads with a -50.8% total return vs HSDT's -99.0%. The 3-year compound annual growth rate (CAGR) favors BEAT at -25.2% vs HSDT's -92.8% — a key indicator of consistent wealth creation.

MetricBEAT logoBEATHeartBeam, Inc.HSDT logoHSDTSolana Company
YTD ReturnYear-to-date-63.4%-28.2%
1-Year ReturnPast 12 months-50.8%-99.0%
3-Year ReturnCumulative with dividends-58.2%-100.0%
5-Year ReturnCumulative with dividends-81.0%-100.0%
10-Year ReturnCumulative with dividends-81.0%-100.0%
CAGR (3Y)Annualised 3-year return-25.2%-92.8%
BEAT leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

BEAT leads this category, winning 2 of 2 comparable metrics.

BEAT is the less volatile stock with a 1.27 beta — it tends to amplify market swings less than HSDT's 2.65 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BEAT currently trades 22.3% from its 52-week high vs HSDT's 0.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBEAT logoBEATHeartBeam, Inc.HSDT logoHSDTSolana Company
Beta (5Y)Sensitivity to S&P 5001.27x2.65x
52-Week HighHighest price in past year$4.00$258.50
52-Week LowLowest price in past year$0.54$1.61
% of 52W HighCurrent price vs 52-week peak+22.3%+0.9%
RSI (14)Momentum oscillator 0–10039.054.2
Avg Volume (50D)Average daily shares traded1.6M295K
BEAT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricBEAT logoBEATHeartBeam, Inc.HSDT logoHSDTSolana Company
Analyst RatingConsensus buy/hold/sell
Price TargetConsensus 12-month target
# AnalystsCovering analysts
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

HSDT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BEAT leads in 2 (Total Returns, Risk & Volatility). 1 tied.

Best OverallHeartBeam, Inc. (BEAT)Leads 2 of 6 categories
Loading custom metrics...

BEAT vs HSDT: Frequently Asked Questions

7 questions · data-driven answers · updated daily

01

Which is the better long-term investment — BEAT or HSDT?

Over the past 5 years, HeartBeam, Inc.

(BEAT) delivered a total return of -81. 0%, compared to -100. 0% for Solana Company (HSDT). Over 10 years, the gap is even starker: BEAT returned -81. 0% versus HSDT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

02

Which is safer — BEAT or HSDT?

By beta (market sensitivity over 5 years), HeartBeam, Inc.

(BEAT) is the lower-risk stock at 1. 27β versus Solana Company's 2. 65β — meaning HSDT is approximately 108% more volatile than BEAT relative to the S&P 500.

03

Which is growing faster — BEAT or HSDT?

On earnings-per-share growth, the picture is similar: Solana Company grew EPS 57.

3% year-over-year, compared to 15. 1% for HeartBeam, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

04

Which has better profit margins — BEAT or HSDT?

HeartBeam, Inc.

(BEAT) is the more profitable company, earning 0. 0% net margin versus -679. 6% for Solana Company — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BEAT leads at 0. 0% versus -351. 0% for HSDT. At the gross margin level — before operating expenses — HSDT leads at 91. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

05

Which pays a better dividend — BEAT or HSDT?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

06

Is BEAT or HSDT better for a retirement portfolio?

For long-horizon retirement investors, HeartBeam, Inc.

(BEAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 27)). Solana Company (HSDT) carries a higher beta of 2. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BEAT: -81. 0%, HSDT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

07

What are the main differences between BEAT and HSDT?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BEAT is a small-cap quality compounder stock; HSDT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BEAT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

HSDT

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 1669%
  • Gross Margin > 55%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.